About Us

Establishment of Larix

Larix International is a private limited company involved in publishing Open Access Science and medicine related journals. The company is run by a team of dedicated editors, reviewers and authors. Over the years, Larix has evolved into one of forerunner in the publishing industry around the world. We continue to lead through the visions of technology, people, and innovation.

Why to publish with Larix?

At present, Larix International scope is to publish high-quality original research papers, case reports and other manuscripts. We promote scientific research with the help of stringent Peer-Review process. We are empowered by eminent group of editors and reviewers. The Editorial Board oversee the stringent multi-level Peer-Review process including evaluating submissions, selecting reviewers and assessing their comments and making editorial decisions.

We foster the open-access policy strongly and offer unrestricted access to the papers published, reproduction and distribution of the manuscripts in any medium, provided the original work is properly cited.

We are dedicated to offer researchers a broad range of services and are well known for providing online publication in an efficient and effective manner.

Vision of Larix

Larix wishes to establish a future trend for growth advancement in science, medicine and technology with the help of scholarly manuscripts. We wish to promote Open Access to facilitate the research literatures available on the public domain free-of-cost and to permit reading or downloading for any lawful purpose.

Mission of Larix

Larix works with a mission to publish, discuss and analyze invaluable research, applications and expert opinions in the versatile field of science, medicine and technology. We aim to bring important scientific works to a wide international audience and therefore only publish original papers with strong and analytical messages that advance our understanding of scientific principles. We ensure that the research presented in the manuscripts must be descriptive, providing insights into scope of the journal.

Editors-in-Chief


Editors

Dr . Ashok Kumar Palakurthi
Quality control Lab Manager
Aurex Laboratories LLC
USA
Dr . Srinath Nissankararao
Pharmaceutical Professional at Drug Design and Discovery
Jawarharlal Nehru Technological University
India
Dr . Dr. Sunitha Reddy M. Pharm., Ph.D., FPGEE, NABP(Mem), R.Ph. USA
Associate Professor
BOS Chairperson, CPS, IST, JNTU
India
Dr . Sandip Narayan Chakraborty Research Asst II
Translational Molecular Pathology
UT MD Anderson Cancer Center
USA
Prof . Prof. Dr. D. Satyavati M. Pharm., Ph.D
Department of Department of Pharmacology
Brilliant Group of Technical Institutions
India
Dr . Koteswara Rao Valasani
Pharmacy
Department of Pharmacology & Toxicology, University of Kansas
USA
Dr . Y. Ganesh Kumar M. Pharm., Ph.D
Associate Professor & HOD
Department of Pharmaceutics, Unity College of Pharmacy
India
Dr . R. Vijay Kumar M.Pharm., Ph.D
Team leader
APPCO Pharma, LLC, USA
India
Dr . Venkatesha Udupa
Senior General Manager
Toxicology, Glenmark Pharmaceuticals Limited
India
Dr . Kannappan Nagappan M. Pharm., Ph.D
Associate Professor
Annamalai University
India
Prof . R. Mannavalan M. Pharm., Ph.D
Prof
Annamalai University
India
Dr . Shaik Harun Rasheed M.Pharm., Ph.D., L.L.B, FAGE, A.I.C
Professor & Head
Department of Pharmaceutics, MRM College of Pharmacy
India
Dr . Sadanandam Palle
DST SERB Fast Track Young Scientist & Co-PI
JNT University
India
Dr . Ajitha M
Professor & OIE
Institute of Science and Technology, JNT-University
India

Reviewers